E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Neuroinfect Dis 2022 (404), Vol 13(7)
  • DOI: 10.4172/2314-7326.1000404

Neurocysticercosis Caused by Invasion of the Larvae into the Central Nervous System: A systematic Review

Hector H Garcia*
Department of Molecular Cell Biology, Amsterdam Infection and Immunity Institute, Peru
*Corresponding Author: Hector H Garcia, Department of Molecular Cell Biology, Amsterdam Infection and Immunity Institute, Peru, Email: hgarcia@jhsph.com

Received: 05-Jul-2022 / Manuscript No. JNID-22-70864 / Editor assigned: 07-Jul-2022 / PreQC No. JNID-22-70864(PQ) / Reviewed: 20-Jul-2022 / QC No. JNID-22-70864 / Revised: 25-Jul-2022 / Manuscript No. JNID-22-70864(R) / Published Date: 29-Jul-2022 DOI: 10.4172/2314-7326.1000404

Abstract

Neurocysticercosis is a disease of poverty and underdevelopment. Little is known about the natural history of the infection in humans, but some of the mechanisms whereby the parasite remains silent and evades the host immune response are understood. Symptomatic neurocysticercosis usually results from host inflammatory response after parasite death, and the clinical manifestations can be diverse. There is no evidence that cysticidal treatment does more good than harm in addition to conventional antiepileptic treatment. Population control measures involving immunisation or mass treatment have not shown long term effectiveness.

Epilepsy, similarly to neurocysticercosis, is a largely unrecognised but increasing burden on the welfare and economies of developing countries. The technology of drug treatment and psychosocial rehabilitation is well known but requires widespread and effective dissemination at low cost. There is little epidemiological data on risk factors for epilepsy in developing countries on which to base prevention strategies. The public health prioritisation of chronic disorders such as epilepsy remains a challenge for policy and practice in developing countries.

For both neurocysticercosis and epilepsy, there is a dilemma about whether limited public resources would better be spent on general economic development, which would be expected to have a broad impact on the health and welfare of communities, or on specific programmes to help individual affected people with neurocysticercosis and epilepsy. Either approach requires detailed economic evaluation.

Introduction

Taeniasis and (neuro) cysticercosis are caused by the cestode Taenia solium or pork tapeworm. T. solium is a multi-host parasite with a complex zoonotic transmission cycle, circulating between the intermediate pig host and the definitive or accidental intermediate human host. T. solium infection arises from ingestion of contaminated food or water and ingestion of raw or undercooked pork and may result in taeniasis (caused by the adult tapeworm living in the small intestine) and/or cysticercosis or neurocysticercosis [NCC; caused by invasion of the larvae into the central nervous system (CNS)] in humans[1].

When humans consume pork containing live T. solium cysts, the cysticercus develops into a mature tapeworm in the human intestine, shedding eggs that are expelled in human feces.

Cysticercosis develops when, following ingestion of T. solium eggs, T. solium larvae migrate and become encysted, typically in the muscle tissue of the host. Pigs can harbour thousands of cysts [2]. When T. solium cysticercisis develop in the human brain, the condition is defined as NCC. NCC is the most common parasitic disease of the CNS in humans affecting between 2.5 and 8.3 million people annually, accounting for a global burden of 2.8 million disability-adjusted life years (DALYs). NCC is a major clinical consequence of T. solium infection and the dominant cause of global preventable epilepsy associated with morbidity and mortality from epileptic seizures and epilepsy related death; where T. solium is endemic, 30% of epilepsy cases are estimated to be caused by NCC.

Taeniasis can cause abdominal pain, nausea, and diarrhoea, although it is often asymptomatic, at around 8 weeks post-ingestion with symptoms persisting until treatment with anthelmintic drugs or for around 2–3 years (the lifespan of the adult tapeworm) if untreated[3]. Many carriers of T. solium (taeniasis and cysticercosis) are asymptomatic and become long-term carriers of infection through self-reinfection and re-infection from others within the household. T.solium infection in pigs can be detected by meat inspection by visual inspection of cut meat and by lingual examination of the live animal; this, however, has low sensitivity as cysts can be missed[4].

Cysticerci consist of two main parts, the vesicular wall and the scolex. After entering the central nervous system, cysticerci are in a vesicular (viable) stage in which the parasites have a transparent membrane, a clear vesicular fluid, and a normal invaginated scolex. Cysticerci may remain viable for years or, as the result of the host’s immunological attack, enter in a process of degeneration that ends with their transformation into calcifications. The first stage of involution of cysticerci is the colloidal stage, in which the vesicular fluid becomes turbid, and the scolex shows signs of hyaline degeneration. Thereafter, the wall of the cyst thickens and the scolex is transformed into mineralized granules; this stage, in which the cysticercus is no longer viable, is called the granular stage. Finally, the parasite remanents appear as a mineralized nodule [5].

Vesicular cysticerci elicit little inflammatory reaction in the surrounding tissue. In contrast, colloidal cysticerci are often surrounded by a collagen capsule and by a mononuclear inflammatory reaction that includes the parasite itself [6]. The surrounding brain parenchyma shows astrocytic gliosis, microglial proliferation, edema, neuronal degenerative changes, and perivascular cuffing of lymphocytes. When parasites enter into the granular and calcified stages, the edema subsides but the astrocytic changes in the vicinity of the lesions may become more intense, and epithelioid cells appear and coalesce to form multinucleated giant cells [7]. Meningeal cysticerci usually elicit a severe inflammatory reaction in the subarachnoid space with formation of an exudate composed of collagen fibres, lymphocytes, multinucleated giant cells, eosinophils, and hyalinized parasitic membranes leading to abnormal thickening of the leptomeninges [8]. This inflammation may be disseminated inducing damage in the optic chiasm and cranial nerves arising from the brainstem, as well as in small penetrating arteries arising from the circle of Willis [9]. The latter may cause occlusion of the lumen of the vessel with the subsequent development of a cerebral infarction. The foramina of Luschka and Magendie may also be occluded by the thickened leptomeninges and parasitic membranes with the subsequent development of obstructive hydrocephalus. Ventricular cysticerci may also elicit an inflammatory reaction if they are attached to the choroid plexus or to the ventricular wall [10]. The disrupted ependymal lining may protrude toward the ventricular cavities blocking CSF transit, particularly when the site of protrusion is at or near the foramina of Monro or the cerebral aqueduct [11].

Diagnosis

The advent of modern neuroimaging tests drastically changed our diagnostic accuracy for neurocysticercosis. CT and MRI provide objective evidence on the number and topography of lesions and their stage of involution Vesicular cysticerci appear on CT and MRI as small and rounded cysts that are well demarcated from the surrounding brain parenchyma [12]. There is no edema and no contrast enhancement. Many of these lesions have in their interior an eccentric hyperdense nodule representing the scolex, giving them a pathognomonic “holewith- dot” appearance [13]. Colloidal and granular cysticerci appear as ill-defined lesions surrounded by edema; most of them show a ring or a nodular pattern of enhancement after contrast medium administration. This pattern correspond is commonly referred as to “cysticercus granuloma” . A particular neuroimaging pattern is that observed in patients with cysticercoid encephalitis [14]. CT and MRI show diffuse brain edema, collapse of the ventricular system without midline shift, and multiple small ring-like or nodular enhancing lesions disseminated within the brain parenchyma. Calcified cysticerci normally appear on CT as small hyperdense nodules without perilesional edema or abnormal enhancement after contrast medium administration [15].

Conclusion

Relatively little is known about the epidemiology of neurocysticercosis, and cysticidal treatments have been advocated without clear evidence for overall benefit in humans. Diagnosis may be difficult even with neuroimaging and serological facilities. Neurocysticercosis is a major cause of acquired epilepsy in Latin American countries. The economic burdens of both are not well quantified. Community prevention and eradication of neurocysticercosis depends on general infrastructural development. Most people with epilepsy in developing countries do not have access to appropriate management. The major challenge for the future will be to develop primary level services that provide appropriate interventions for these communities.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Amudhan S, Gururaj G, Satishchandra P (2015) Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol 18: 263-277.
  2. Indexed at, Google Scholar, Crossref

  3. Nash TE, Garcia HH (2011) Diagnosis and Treatment of Neurocysticercosis. Nature reviews Neurology 7: 584-594.  
  4. Indexed at, Google Scholar, Crossref

  5. Garcia HH, Nash TE, Del Brutto OH (2014) Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol 13: 1202-1215.   
  6. Indexed at, Google Scholar, Crossref

  7. Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chávez-Macías L, Perochena A, et al. (2010) Neurocysticercosis: radiologic-pathologic correlation. Radiographics 30: 1705-1719.
  8. Indexed at, Crossref

  9. Lerner A, Shiroishi MS, Zee CS (2012) Imaging of neurocysticercosis. Neuroimaging Clin N Am 22: 659.
  10. Indexed at, Google Scholar, Crossref

  11. Castillo M (2004) Imaging of neurocysticercosis. Semin Roentgenol 39: 465-473.
  12. Indexed at, Google Scholar, Crossref

  13. Hingwala,  Divyata  (2011) Applications of 3D CISS Sequence for Problem Solving in Neuroimaging. The Indian Journal of Radiology Imaging 21:  90-97.
  14. Indexed at, Google Scholar, Crossref

  15. Govindappa SS, Narayanan JP, Krishnamurthy VM (2000) Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequence. AJNR Am J Neuroradiol 21: 679-684.
  16. Indexed at, Google Scholar

  17. Zhao J L, Lerner A, Sh Z, Gao X J, Zee C S (2015) Imaging spectrum of neurocysticercosis. Radiology of Infectious Diseases 1: 94-102.
  18. Indexed at, Google Scholar, Crossref

  19. Braga F, Rocha A J, Gomes H R, Hernandez Filho G, Fonseca RB (2004) Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O2 in the evaluation of neurocysticercosis. AJNR Am J Neuroradiol 25:  295-297.
  20. Indexed at, Google Scholar

  21. Garcia H H, Castillo Y, Gonzales I, Bustos J A , Saavedra H, et al. (2018)  Cysticercosis Working Group in Peru. Low sensitivity and frequent crossreactions in commercially available antibody detection ELISA assays for Taenia solium cysticercosis. Tropical Medicine & International Health 23: 101-105.
  22. Indexed at, Google Scholar, Crossref

  23. Padma M V, Behari M, Misra N K ,Ahuja G K (1995) Albendazole in neurocysticercosis.  Natl Med J India 8: 255-258.
  24.       Indexed at, Google Scholar

  25. Padma M V, Behari M, Misra N K, Ahuja G K (1994) Albendazole in single CT ring lesions in epilepsy. Neurology 44: 1344-1344.
  26.                 Google Scholar, Crossref

  27. Garcia H H, Lescano A G, Lanchote V L, Pretell E J, Gonzales I, et al. (2011). Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. British journal of clinical pharmacology 72: 77-84.
  28. Indexed at

  29. Abba, Katharine, Sridharan Ramaratnam, Ranganathan L N (2010) Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 3.
  30. Indexed at, Google Scholar, Crossref

Citation: Garcia HH (2022) Neurocysticercosis Caused by Invasion of the Larvae into the Central Nervous System: A systematic Review. J Neuroinfect Dis 13: 404. DOI: 10.4172/2314-7326.1000404

Copyright: © 2022 Garcia HH. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top